Announced Wed, 15 Jul · 11:02 IST
Q1 FY27 Results Published in Newspapers; PAT Falls 86% YoY
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+1.0%1-day move
₹23.31
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+1.0+0.8+2.5+0.8-0.6-1.8————
Up moveDown movePending
AI summary
Vivo Bio Tech published Q1 FY27 (quarter ended June 30, 2026) unaudited results in newspapers as required under SEBI rules. Consolidated total income rose 14% YoY to Rs 1,427.97 lakh from Rs 1,251.16 lakh. But profit after tax fell sharply to Rs 18.76 lakh from Rs 133.71 lakh, a drop of about 86% YoY. Standalone PAT was Rs 16.43 lakh vs Rs 132.32 lakh.
Likely market impact
Sharp fall in quarterly profit despite higher revenue suggests margin pressure. Investors may react negatively to the weak earnings print.